Non-Peptidic Inhibitors of Cysteine Proteases

被引:35
作者
Schirmeister, T. [1 ]
Kaeppler, U. [1 ]
机构
[1] Univ Wurzburg, Dept Pharmaceut Chem, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
D O I
10.2174/1389557033488079
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In comparison to the huge number of peptidic and peptidomimetic inhibitors of cysteine proteases which have been developed during the last twenty years the number of non-peptidic compounds with cysteine protease inhibiting properties is restricted to a few substance classes. In contrast to peptidic and peptidomimetic inhibitors the non-peptidic lead structures have mainly been discovered by computational or enzymatic industrial screenings and not by a rational approach. But, the growing number of resolved X-ray structures of the target enzymes as well as molecular modeling methods have supported the further development of potent inhibitors beginning from these lead structures. In this review we will focus on new non-peptidic cysteine protease inhibitors which have been developed during the last years. Discovery, structure-activity-relationship and inhibition mechanisms will be discussed.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 87 条
  • [1] Tellurium compounds: Selective inhibition of cysteine proteases and model reaction with thiols
    Albeck, A
    Weitman, H
    Sredni, B
    Albeck, M
    [J]. INORGANIC CHEMISTRY, 1998, 37 (08) : 1704 - 1712
  • [2] Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin
    Banik, NL
    Matzelle, D
    Terry, E
    Gantt-Wilford, G
    Hogan, EL
    [J]. NEUROCHEMICAL RESEARCH, 2000, 25 (11) : 1509 - 1515
  • [3] Evolutionary lines of cysteine peptidases
    Barrett, AJ
    Rawlings, ND
    [J]. BIOLOGICAL CHEMISTRY, 2001, 382 (05) : 727 - 733
  • [4] BROMME D, 1987, BIOCHEM J, V245, P381
  • [5] Buhling F., 2000, CELLULAR PEPTIDASES, V2
  • [6] Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290
  • [7] A comparison of the enzymatic properties of the major cysteine proteinases from Trypanosoma congolense and Trypanosoma cruzi
    Chagas, JR
    Authie, E
    Serveau, C
    Lalmanach, G
    Juliano, L
    Gauthier, F
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1997, 88 (1-2) : 85 - 94
  • [8] LICOCHALCONE-A, A NEW ANTIMALARIAL AGENT, INHIBITS IN-VITRO GROWTH OF THE HUMAN MALARIA PARASITE PLASMODIUM-FALCIPARUM AND PROTECTS MICE FROM P-YOELII INFECTION
    CHEN, M
    THEANDER, TG
    CHRISTENSEN, SB
    HVIID, L
    ZHAI, L
    KHARAZMI, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) : 1470 - 1475
  • [9] The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo
    Chen, M
    Christensen, SB
    Zhai, L
    Rasmussen, MH
    Theander, TG
    Frokjaer, S
    Steffansen, B
    Davidsen, J
    Kharazmi, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) : 1327 - 1333
  • [10] Inhibition of fumarate reductase in Leishmania major and L-donovani by chalcones
    Chen, M
    Zhai, L
    Christensen, SB
    Theander, TG
    Kharazmi, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2023 - 2029